Micro-Cap Pharma Company Expands Partnership

By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, September 22, 2020

In times of uncertainty stemming from stock market selloffs, one thing I like to do is identify companies/sectors that are actually making bullish moves and figuring out the underlying cause behind them. It didn’t take me long to recognize a nice move for a small Canadian-based specialty pharmaceutical company, Aequus Pharmaceuticals Inc. (TSX-Venture:AQS), after it made headlines this morning.

The company announced the expansion of a partnership with Medicom Healthcare to include an additional formulation in a preservative free dry eye product line. This news is coming just days after the company has also submitted an application for the product with Health Canada for processing of a New Medical Device License. Doug Janzen, the CEO and Chairman of Aequus believes that they are “more than ready now, for the anticipated approval of these three Evolve products in Canada, that will be launching into a $90 million dry eye market.”

This was welcomed news to shareholders, as the company traded up to $.145/share for a 7.4% pop. This is following a healthy uptrend for the last three months after the company nearly made all-time lows in July. With this company making great strides to potentially expand their operations, you might want to add them to your watchlist!

Copyright © 2020 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.